Pharmgen science is moving forward that establish competitive pipeline for innovative new drugs of digestive diseases, IMD (incrementally modified drug) and first-generic drugs. Based on continuous investment of R&D, we are constantly challenging ourselves for joint research with other institutions, organic networks and new drugs. Hence, we will grow into R&D company that realizes ‘Well Being Life’.
New Drug Research Institute
We are focusing on the development of innovative first-in class and best-in class drugs targeting digestive and autoimmune diseases based on professional research team with full-cycle drug development experience.
Central Research Institute
Based on highly professional researchers and high tech infrastructures, we were produced new drugs such as VARDIPINE Tab., ANTHROM Tab., ESOMEX Tab., LIVATIN Tab. along with NEUROS Cap. and we are focusing on developing new IMDs (incrementally modified drug) and competitive generic products.
